Philip Patston, D.Phil.,
Associate Professor,
Department of Oral Medicine and Diagnostic Sciences,
College of Dentistry,
University of Illinois at Chicago
Research Interests
My laboratory studies various aspects of the mechanism, regulation, structure,
and function of the serpin family of proteins. Serpins are a
large family of structurally related proteins many (but not all)
of which are serine proteinase inhibitors.
An inhibitory serpin which is actively studied is C1-inhibitor,
the only inhibitor of complement C1r and C1s proteinases, and an
important inhibitor of plasma kallikrein and factor XIIa. Using
Swiss-Model and Rasmol this is a modeled structure of cleaved C1-inhibitor. Currently we are investigating the role
played by endothelial cells in regulating the inhibition of plasma kallikrein by
C1-inhibitor, and using another serpin, alpha1-proteinase inhibitor, to design
C1-inhibitor mimetics.
The non-inhibitory serpins under investigation are angiotensinogen and thyroxine binding
globulin.
Selected Publications
- PA Patston, P Gettins, J Beechem, and M Schapira (1991)
Mechanism of serpin action. Evidence that C1-inhibitor
functions as a suicide substrate. Biochemistry 30,
8876-8882
- K Skriver, WR Wikoff, PA Patston, F Tausk, M Schapira, AP
Kaplan, and SC Bock (1991) Substrate properties of C1-inhibitor
Ma (Alanine 434 to Glu). J. Biol.
Chem. 266, 9216-9221
- P Gettins, PA Patston, and M Schapira (1993)The role of
conformational change in serpin structure and function. Bioessays
15, 461-467
- PA Patston, RL Medcalf, Y Kourteva, and M Schapira (1993)
C1-inhibitor-serine proteinase complexes and the
biosynthesis of C1-inhibitor. Blood 82, 3371-3379
- PA Patston, and PGW Gettins (1994) A database of wild
type and mutant recombinant serpins. Thromb. Haemost.
72, 166-179
- PA Patston, and M Schapira (1994) Low affinity heparin
stimulates the inactivation of plasminogen activator
inhibitor-1 by thrombin. Blood 84, 1164-1172
- PA Patston, PGW Gettins, and M Schapira (1994) Serpins
are suicide substrates: Implications for the regulation
of proteolytic pathways. Semin. Thromb. Hemost. 20,
410-416
- JA Huntington, PA Patston, and PGW Gettins (1995) S-ovalbumin,
an ovalbumin conformer with properties analogous to those
of loop-inserted serpins. Protein Sci. 4, 613-621
- PA Patston, J Hauert, M Michaud, and M Schapira (1995)
Formation and properties of C1-inhibitor polymers. FEBS
Lett. 368, 401-404
- PGW Gettins, PA Patston, and ST Olson (1996)Serpins.
Structure, Function and Biology. R.G. Landes, pp220 (Book)
- PA Patston, and PGW Gettins (1996) Significance of
secondary structure predictions on the reactive center
loop region of serpins. A model for the folding of
serpins into a metastable state. FEBS Lett. 383,
87-92
- PA Patston, and M Schapira (1997) Regulation of C1-inhibitor
activity by binding to type IV collagen and heparin. Biochem.
Biophys. Res. Commun. 230, 597-601
- ST Olson, R Swanson, PA Patston, and I Björk (1997)
Apparent formation of sodium dodecyl sulfate-stable
complexes between serpins and 3,4-dichloroisocoumarin-inactivated
proteinases is due to regeneration of active proteinase
from the inactivated enzyme. J. Biol. Chem. 272,
13338-13342
- M. Gauthier, and PA Patston (1997) Reactivation of C1-inhibitor
polymers by denaturation and gel-filtration
chromatography. Analyt. Biochem. 248, 228-233
- CE Chaillan-Huntington, PGW Gettins, JA Huntington, and
PA Patston (1997) The P6-P2 region of serpins is
critical for proteinase inhibition and complex stability.
Biochemistry 36, 9562-9570
- CE Chaillan-Huntington, and PA Patston (1998)
Influence of the P5 residue on alpha-1-proteinase
inhibitor mechanism. J. Biol. Chem. 273, 4569-4573
- J Hauert, PA Patston, and M Schapira (2000) C1-inhibitor
cross-linking by tissue transglutaminase. J. Biol.
Chem. 275, 14558-14562
- I Simonovic and, PA Patston (2000) The native metastable
fold of C1-inhibitor is stabilized by disulfide bonds. Biochim.
Biophys. Acta 1481, 97-102
- PA Patston (2000) Serpins and other serine protease
inhibitors. Immunol. Today 21, 354 (Letter to the
Editor)
- S Suda, PGW Gettins, and PA Patston (2000) Linkage
between the hormone binding site and the reactive center loop of thyroxine
binding globulin. Arch. Biochem. Biophys. 384, 31-36
- T Sulikowski, and PA Patston (2001) The inhibition of TNK-t-PA
by C1-inhibitor. Blood. Coag. Fibrinolys. 12, 75-77
- A Ramaha, and PA Patston (2002) Release and degradation of angiotensin I
and angiotensin II from angiotensinogen by neutrophil proteinases. Arch.
Biochem. Biophys. 397, 77-83
- T Sulikowski, BA Bauer, and PA Patston (2002) Alpha1-Proteinase
inhibitor reactive center loop mutants with specificity for kallikrein and
C1s but not C1. Protein Sci., 11, 2230-2236
- EW Brown, S Ravindran, and PA Patston (2002) The reaction between
plasmin and C1-inhibitor results in plasmin inhibition by the serpin
mechanism. Blood Coag. Fibrinolys., 13, 711-714.
- A Ramaha, J. Célérier, and PA Patston (2003) Characterization of
different high molecular weight angiotensinogen forms. Am. J. Hypertens.
16, 478-483.
- PA Patston, F Church, and ST Olson (2004) Ligand binding to
serpins. Methods 32, 93-109.
Philip Patston, D.Phil.
Department of Oral Medicine and Diagnostic Sciences
University of Illinois-Chicago (MC 838)
801 South Paulina Street
Chicago, IL 60612
TEL: 312 996-8554; FAX: 312 355-2688;
E-mail: patston@uic.edu
Return to the Oral Medicine
faculty page.
Last Modified on January 20, 2004